The Supreme Court on Wednesday slammed the Centre's paid Covid-19 vaccination policy for the 18-44 age group, calling it “arbitrary and irrational”. The Supreme Court’s observation came days after it said that vaccine prices should be uniform across the country. Currently, the Centre’s vaccination policy provides for free vaccination for those 45 and above and a paid system for those between 18-44 age group. In another story, with an aim to pave the way for the availability of vaccines like Pfizer and Moderna in India, the Drugs Controller General of India (DCGI) has exempted foreign Covid-19 vaccines approved by specific nations or health bodies from post-approval bridging trials in the country. DCGI chief VG Somani said the decision to waive trials will only apply to the vaccines that have been approved for restricted use by the US FDA and other countries or which are listed on the WHO Emergency Use Listing (EUL). Watch the full show for more!
